PAYD COVID-19 Services
Willing Hearts, Helpful Hands
PAYD COVID-19 Services
Drive-thru COVID-19 is now available on the campus of the Parker Jewish Institute for Health Care and Rehabilitation in New Hyde Park.
In collaboration with our laboratory, Parker at Your Door is offering drive-thru and walk-thru testing for the coronavirus disease 2019 (COVID-19) in conveniently located in New Hyde Park on the border between Long Island and New York City.
Parker at Your Door offers the nasal “swab” test. This nasal swab test determines if you have COVID-19 now. We offer the PCR test with results in 24-48 hours and a rapid test which will give you results in 15 minutes.
COVID testing requires an appointment; administration fee is $75 for a PCR and $150 for a rapid test. The cost of the test will be billed to insurance. Candidates must bring valid identification, insurance cards, and credit card.
If you have questions, call our dedicated hotline at 718-289-2606. Our hotline is open 10 a.m. to 4 p.m. Monday through Friday. You’ll be connected with a medical professional who will assist you with scheduling an appointment for drive-thru or walk-thru testing.
We are also providing testing for people, 15 years or older, who require a clearance for work. Medicare and all major credit cards accepted.
COVID-19 vaccination requires an appointment; fees are billed directly to insurance. An appointment for the second vaccination will be provided at the time the first vaccination is given. Candidates must bring valid identification and insurance cards.
If you are making an appointment for a vaccine, please complete the following form and have it with you: Covid 19 Immunization Screening and Consent Form
We are now offering the third dose of the Pfizer Covid vaccine to those who qualify. For more information and to see who is eligible please click here.
If you have scheduled your third vaccine, please complete this form and bring with you.
WE HAVE TWO OPTIONS TO SCHEDULE AN APPOINTMENT:
Opportunities to Participate in Clinical Research Study
While Alzheimer’s disease can be devastating to patients, families, and their caregivers, clinical trials are looking at new ways to fight this disease and are great opportunities to participate and make a difference.
Hope Through Research
The Rethink-ALZ trial is now open to qualifying participants. The trials last for 52 weeks. If you enroll into this trial, you will receive either the oral study drug or placebo twice a day. A placebo looks like the study drug but has no impact on the person taking it. There is no cost to the patient to participate in the Rethink-ALZ trial or for any of the study-related procedures. No hospitalization is required. If you or a loved one are interested in participating in one of these studies, the following criteria must be met:
- Be ages 50 to 87 years old.
- Be diagnosed with, or have a suspected clinical diagnosis of, Alzheimer’s disease.
- Have a gradual change in memory for six months or more.
- Have a family member or loved one who can be available as a study partner during the entire study.
- Be fully vaccinated for COVID-19 or have had a previous COVID-19 infection.
Other criteria will apply.
Paving a Better Future
Agitation associated with Alzheimer’s dementia can be difficult to manage and can be very challenging for patients and their loved ones. The ASPECTTM clinical research study is evaluating an investigational drug for agitation associated with Alzheimer’s dementia and participants are needed. Participants will not have to pay for the study drug (the investigational drug or placebo), study supplies, study visits, or study tests. Health insurance is not required. To be eligible, participants must:
- Be between the ages of 50 and 90.
- Have a diagnosis of probable Alzheimer’s dementia.
- Have moderate-to-severe agitation that interferes with their daily life.
- Have a reliable caregiver who is able to comply with all study procedures
.Other criteria will apply.